[Sequential cancer of concomitant cancer?]
1Zentrum für operative Medizin, Friedrich-Wilhelms-Universität, Bonn.
Zentralblatt Fur Chirurgie
|January 1, 1992
Summary
The polyp-cancer sequence hypothesis is likely incorrect. Colorectal cancer arises from a widespread mucosal abnormality, not solely from polyp progression, with polyp-carcinoma concomitance being more accurate.
Area of Science:
- Gastroenterology
- Oncology
- Cell Biology
Context:
- The traditional polyp-cancer sequence hypothesis suggests colorectal cancer develops sequentially from polyps.
- However, observed differences in polyp and cancer distribution challenge this linear progression model.
- Emerging evidence points to distinct etiological factors influencing polyp formation, growth, and malignant transformation.
Purpose:
- To re-evaluate the prevailing polyp-cancer sequence hypothesis.
- To investigate the etiological factors in colorectal polyp and cancer development.
- To propose a more accurate model for colorectal carcinogenesis.
Summary:
- The study challenges the polyp-cancer sequence hypothesis, finding its distribution inconsistent with cancer distribution in the large intestine.
- Most polyps (90%) are small and do not progress to cancer.
- Colorectal cancer (5%) development is linked to a diffusely abnormal large bowel mucosa, making polyp-carcinoma concomitance a more plausible explanation.
Impact:
- This research reframes the understanding of colorectal cancer origins.
- It suggests that early detection and prevention strategies may need to consider the broader mucosal environment.
- The findings could lead to revised screening protocols and therapeutic approaches for colorectal cancer.
Related Concept Videos
02:18Cancer
55.0K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
55.0K
02:21Cancers Originate from Somatic Mutations in a Single Cell
15.1K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
15.1K
02:07Tumor Progression
7.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.5K
01:03Rous Sarcoma Virus (RSV) and Cancer
6.5K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
6.5K
02:40Cancer Stem Cells and Tumor Maintenance
6.1K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.1K
02:50Combination Therapies and Personalized Medicine
6.2K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K